Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan-Mar;17(1):30-36.
doi: 10.5005/jp-journals-10078-1395.

Clinical Outcomes of Micropulse Transscleral Cyclophotocoagulation: 2 Years of Experience in Portuguese Eyes

Rita C Basto  1 , Júlio Almeida  2 , Joana N Roque  2 , Susana P Henriques  2 , Ana S Gonçalves  2 , Fernando T Vaz  2 , Helena Carvalho  3 , Isabel Prieto  2
Affiliations

Clinical Outcomes of Micropulse Transscleral Cyclophotocoagulation: 2 Years of Experience in Portuguese Eyes

Rita C Basto et al. J Curr Glaucoma Pract. 2023 Jan-Mar.

Abstract

Aim: This study evaluates the safety and efficacy of micropulse transscleral cyclophotocoagulation (MPTSCPC) in glaucoma patients, with standard parameters, over a 24-month period.

Methods: Retrospective analysis of 61 eyes undergoing MPTSCPC from January 2018 to December 2020 was carried out. Patients received 160 seconds of laser, with settings of 2000 mW/cm2 and a duty cycle of 31.3%.

Results: A total of 61 eyes were included, arranged in an age distribution of 73.9 ± 10.8 years. The most frequent diagnosis was primary open-angle glaucoma (POAG), with a mean best-corrected visual acuity (BCVA) of 5/10 in the Snellen Visual chart. Around 37.7% of the eyes had undergone at least one glaucoma filtration surgery prior to MPTSCPC. The mean pretreatment intraocular pressure (IOP) was 24.9 ± 8.6 mm Hg. Except for the contrast at 24 months, at every other follow-up visit, there was a significant reduction (p ≤ 0.001) in IOP and in the number of topical drugs required to control IOP, from four (baseline) to three, with oral acetazolamide suspension in most cases. The total success rate (absolute and clinical successes combined) was 81.9% after 1 year of the treatment. There was no drop in visual acuity or cases of serious complications. There is a positive and significant correlation between prior glaucoma surgery and the need for reinterventions (p = 0.028).

Conclusions: Micropulse transscleral cyclophotocoagulation (MPTSCPC) is an effective and safe procedure for reducing IOP within a broad spectrum of glaucoma patients. Additional studies are needed to confirm the current indications, widen their scope, and determine the optimal treatment settings on an individual basis.

How to cite this article: Basto RC, Almeida J, Roque JN, et al. Clinical Outcomes of Micropulse Transscleral Cyclophotocoagulation: 2 Years of Experience in Portuguese Eyes. J Curr Glaucoma Pract 2023;17(1):30-36.

Keywords: Diode laser; Glaucoma; Goldmann applanation tonometry; Intraocular pressure; Laser therapy; Micropulse transscleral cyclophotocoagulation; Refractory glaucoma; Treat and follow-up of glaucoma.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: None

Figures

Fig. 1
Fig. 1
Mean IOP during the follow-up period
Fig. 2
Fig. 2
Intraocular pressure (IOP) distribution at each time point
Fig. 3
Fig. 3
Mean IOP reduction from baseline during the follow-up period
Fig. 4
Fig. 4
Relationship between diagnosis and success
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Kuchar S, Moster MR, Reamer CB, et al. Treatment outcomes of micropulse transscleral cyclophotocoagulation in advanced glaucoma. Lasers Med Sci. 2016;31(2):393–396. doi: 10.1007/s10103-015-1856-9. - DOI - PubMed
    1. Dastiridou AI, Katsanos A, Denis P, et al. Cyclodestructive procedures in glaucoma: a review of current and emerging options. Adv Ther. 2018;35(12):2103–2127. doi: 10.1007/s12325-018-0837-3. - DOI - PMC - PubMed
    1. Vig N, Ameen S, Bloom P, et al. Micropulse transscleral cyclophotocoagulation: initial results using a reduced energy protocol in refractory glaucoma. Graefes Arch Clin Exp Ophthalmol. 2020;258(5):1073–1079. doi: 10.1007/s00417-020-04611-0. - DOI - PubMed
    1. Toyos MM, Toyos R. Clinical outcomes of micropulsed transcleral cyclophotocoagulation in moderate to severe glaucoma. J Clin Exp Ophthalmol. 2016;7(6):620. doi: 10.4172/2155-9570.1000620. - DOI
    1. Yelenskiy A, Gillette TB, Arosemena A, et al. Patient outcomes following micropulse transscleral cyclophotocoagulation: intermediate-term results. J Glaucoma. 2018;27(10):920–925. doi: 10.1097/IJG.0000000000001023. - DOI - PubMed

LinkOut - more resources